![Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma]()
Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcomaMart??n-Carbonero, Luz; Barrios, Ana; Saballs, Pere; Sirera, Guillem; Santos, Jesus; Palacios, Rosano; Valencia, M Eulalio; Alegre, Marta; Podzamczer, Daniel; Gonz??lez-Lahoz, Juan · AIDS · 2004